Evidence map›Paper›PMID 38651634›Full record

ReviewNanomedicine (London, England)2024

Secondary metabolites in topical infectious diseases and nanomedicine applications.

Ankit Sahoo, Khusbu Dwivedi, Waleed H Almalki, Ashok Kumar Mandal, Abdurrahman Alhamyani, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Nabil K Alruwaili, Pradip Kumar Yadav, Md Abul Barkat and 2 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 3 countries.

Ankit SahooCollege of Pharmacy, J.S. University, Shikohabad, Firozabad, Utta Pradesh, 283135, India.
Khusbu DwivediDepartment of Pharmaceutics, Shambhunath Institute of Pharmacy, Jhalwa, Prayagraj, 211015, Uttar Pradesh, India.
Waleed H AlmalkiDepartment of Pharmacology & Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, 21955, Saudi Arabia.
Ashok Kumar MandalDepartment of Pharmacology, Faculty of Medicine, University Malaya, Kuala Lumpur, 50603, Malaysia.
Abdurrahman AlhamyaniPharmaceuticals Chemistry Department, Faculty of Clinical Pharmacy, Al-Baha University, Alaqiq, 65779-7738, Saudi Arabia.
Obaid AfzalDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
Abdulmalik Saleh Alfawaz AltamimiDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
Nabil K AlruwailiDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakakah, Saudi Arabia.
Pradip Kumar YadavDepartment of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, 786004, Assam, India.
Md Abul BarkatDepartment of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Al-Batin, 39524, Saudi Arabia.
Tanuja SinghCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 10025, India.
Mahfoozur RahmanDepartment of Pharmaceutical Sciences, Shalom Institute of Health & Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, 211007, Uttar Pradesh, India.ORCID 0000-0002-5616-4026
Prince Sattam Bin Abdulaziz University · SAAl Baha University · SADibrugarh University · INJamia Millia Islamia · INJouf University · SASam Higginbottom Institute of Agriculture · INUmm al-Qura University · SAUniversity of Hafr Al-Batin · SAUniversity of Malaya · MY

Funding

Deanship for Research & Innovation, Ministry of Education in Saudi Arabia IFP22UQU4310387DSR158
6 · The paper itself

Abstract

Topical infection affects nearly one-third of the world's population; it may result from poor sanitation, hygienic conditions and crowded living and working conditions that accelerate the spread of topical infectious diseases. The problems associated with the anti-infective agents are drug resistance and long-term therapy. Secondary metabolites are obtained from plants, microorganisms and animals, but they are metabolized inside the human body. The integration of nanotechnology into secondary metabolites is gaining attention due to their interaction at the subatomic and skin-tissue levels. Hydrogel, liposomes, lipidic nanoparticles, polymeric nanoparticles and metallic nanoparticles are the most suitable carriers for secondary metabolite delivery. Therefore, the present review article extensively discusses the topical applications of nanomedicines for the effective delivery of secondary metabolites.

Indexed as

NanomedicineNanoparticlesAdministration, TopicalAnimalsAnti-Infective AgentsCommunicable DiseasesDrug Delivery SystemsHumansLiposomesSecondary MetabolismAnti-Infective AgentsLiposomesbacteriafunginanomedicinenanotoxicologysecondary metabolitesskintopical infectionvirus

Identifiers

PMID38651634
PMCPMC11418228
OpenAlexW4395048894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.